Evaluation of Clinical Trial Termination and Subgroup Insights

This chapter examines the early termination of a clinical trial due to futility, highlighting insights from the data safety monitoring board's evaluation. It also discusses the implications for patient subgroups, particularly those with end-stage renal disease, and presents intriguing results that warrant further investigation.